The document discusses the regulatory requirements for package inserts in India. Package inserts are documents approved by authorities that are provided with drug packages to inform safe and effective use. In India, the Drugs and Cosmetics Act and Rules govern package inserts and require certain information under Section 6 of Schedule D, including therapeutic indications, dosage, administration method, warnings, interactions and adverse effects. Package inserts are primarily intended to inform healthcare professionals but can also include patient information leaflets in non-technical language.